Young-Sik Cho
Chairman at BIONOTE, INC.
Net worth: 981 M $ as of 31/03/2024
Profile
Dr. Young-Sik Cho is a Principal at BioNote, Inc. He is on the Board of Directors at SD Biosensor, Inc. Dr. Cho was previously employed as a Chief Executive Officer by Abbott Diagnostics Korea, Inc. He received his doctorate degree from Seoul National University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SD BIOSENSOR, INC.
65.23% | 28/03/2024 | 81,198,713 ( 65.23% ) | 712 M $ | 31/03/2024 |
BIONOTE, INC.
60.06% | 26/12/2023 | 61,248,000 ( 60.06% ) | 196 M $ | 31/03/2024 |
EUBIOLOGICS CO., LTD.
18.43% | 11/04/2024 | 6,719,153 ( 18.43% ) | 60 M $ | 31/03/2024 |
CTC BIO INC.
8.70% | 26/12/2023 | 2,103,798 ( 8.70% ) | 14 M $ | 31/03/2024 |
Young-Sik Cho active positions
| Companies | Position | Start |
|---|---|---|
| BIONOTE, INC. | Chairman | 01/03/2023 |
| SD BIOSENSOR, INC | Chairman | - |
Former positions of Young-Sik Cho
| Companies | Position | End |
|---|---|---|
Abbott Diagnostics Korea, Inc.
 Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Chief Executive Officer | - |
Training of Young-Sik Cho
| Seoul National University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SD BIOSENSOR, INC | Electronic Technology |
| Private companies | 2 |
|---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
| BioNote, Inc. |
- Stock Market
- Insiders
- Young-Sik Cho